BriaCell Therapeutics Cor...

NASDAQ: BCTX · Real-Time Price · USD
0.74
0.00 (0.14%)
At close: Aug 15, 2025, 3:59 PM
0.76
2.72%
Pre-market: Aug 18, 2025, 08:25 AM EDT

BriaCell Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is August - July.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020
Net Income
-6.22M -6.34M -5.83M -1.25M 1.69M -11.33M 5.96M -2.42M -4.9M -11.88M -1.11M -15.75M -4.84M -3.87M -2.39M -2.72M 3.02M -357.15K -365.25K
Depreciation & Amortization
26.66K 26.05K 26.66K 72.44K 3.82K 3.82K 3.82K 3.82K 3.82K 3.82K 3.82K 3.82K 3.82K 3.82K 3.82K 3.81K 4.12K 3.81K 3.52K
Stock-Based Compensation
224.81K 285.09K 266.97K 377.89K 392.21K 500.15K 533.82K 533.82K 281.19K 266.84K 1.11M -130.12K 1.59M 1.1M 518.13K -40.56K 2.01M n/a n/a
Other Working Capital
637.86K 100.16K 92.44K 1.28M 5.03M -1.44M 870.15K -4.07M -594.68K 239.16K 237.72K 969.17K -1.6M 344.08K -50.44K n/a -3.32M 52.21K 382.82K
Other Non-Cash Items
-113.09K -763.65K 688.16K -4.53M -14.23M 1.59M -14.28M -5.09M -539.43K 7.63M -4.12M 11.58M 29.91K -60.15K 978.00 1.82M -3.26K -4.92K 6.15K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 105.79K -1.07M -7.78M n/a n/a
Change in Working Capital
-1.08M 870.11K -2.11M 1.29M 3.74M 1.84M 180.33K -3.95M -181.88K 29.86K 566.19K 969.16K -1.6M 264.89K -21.1K 62.78K -2.79M 146.06K 302.01K
Operating Cash Flow
-7.16M -5.92M -6.96M -4.04M -5.08M -7.4M -7.61M -10.92M -5.33M -3.95M -3.54M -3.33M -4.82M -2.56M -1.78M -1.94M -5.54M -212.2K -53.57K
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
-105K -75K -75K n/a -225K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a -304.27K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -456.8K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-105K -75K -75K -456.8K -225K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -13.18 841.31 826.80 0.00
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 207.74 -574.65K 214.62K 27.1K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a -0.5 -412.42 -47.29K -102.67K -21.4K -12.78M n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 527.76K 293.25K n/a n/a n/a n/a 1.37M 1.59K n/a n/a -57.12K 1.38M 1.27M n/a 16.4M -6.09M 49.04K 9K
Financial Cash Flow
14.71M 5.22M 11.96M 4.42M n/a n/a n/a 4M 1.59K -412.42 -47.29K -159.78K 1.37M -4.95M n/a 38.27M 26.49M 207.31K 24.99K
Net Cash Flow
7.45M -778.61K 4.93M -73.61K -5.31M -7.4M -7.61M -6.92M -5.33M -3.95M -3.59M -3.49M -3.45M -7.51M -1.78M 37.19M 20.07M -726.88 -13.15K
Free Cash Flow
-7.16M -5.92M -6.96M -4.04M -5.08M -7.4M -7.61M -10.92M -5.33M -3.95M -3.54M -3.33M -4.82M -2.56M -1.78M -1.94M -5.54M -212.2K -53.57K